Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kazakov (Moscow, Russian Federation), G. Mojokina (Moscow, Russian Federation), S. Smerdin (Moscow, Russian Federation), V. Aksenova (Moscow, Russian Federation), N. Klevno (Moscow, Russian Federation). The frequency of cases of hepatotoxic reactions in first diagnosed patients with pulmonary tuberculosis. 526

Member's Comments

No comment yet.

Related content which might interest you: Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002 The profile of patients with pulmonary and extrapulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Prevalence, features of the course and treatment efficacy airway obstruction in patients with newly diagnosed pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Adverse reactions in the treatment of patients with non-tuberculous pulmonary mycobacteriosis. Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Endobrochites of specific genesis in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004 Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 197s Year: 2007 The latent tuberculosis infection among household contacts of newly diagnosed patients with sputum-positive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 142s Year: 2003 An analysis of cases diagnosed with tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 9s Year: 2006 The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 6s Year: 2006 Assessment of the prevalence of pulmonary involvement in cases with extrapulmonary tuberculosis Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis Year: 2011 Prevalence of dyspnoea in patients with treated pulmonary tuberculosis Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006 Diagnosis and treatment delay in patients with pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003 Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Treatment results of cases of severe pulmonary tuberculosis with using rifabutin Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Pulmonary tuberculosis relapses: A report of 44 cases Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 The diagnosis and treatment results of new diagnosed tuberculosis cases Source: Eur Respir J 2002; 20: Suppl. 38, 166s Year: 2002